Given the autocrine/paracrine role of extracellular ATP in hypoxia-induced VV angiogenesis, the results from our study may suggest development of new therapeutic strategies to limit pathological angiogenesis in cardiovascular diseases via simultaneous targeting of purinergic receptors and cellular metabolic pathways. This evidence concerns the gene P2RY1 and cardiovascular disorder.